{"count": 1, "results": [{"_id": "36326609", "pmid": 36326609, "title": "An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy.", "journal": "Biomater Sci", "authors": ["Yang M", "Li J", "Liu Z", "Zhang H", "Liu J", "Liu Y", "Zhuang A", "Zhou H", "Gu P", "Fan X"], "date": "2022-12-06T00:00:00Z", "doi": "10.1039/d2bm01058e", "meta_date_publication": "2022 Dec 6", "meta_volume": "10", "meta_issue": "24", "meta_pages": "7077-7092", "score": 50260.793, "text_hl": "Here, a novel strategy based on an injectable vitreous substitute with sustained @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ release ability (IVS-Met) was reported for efficient @DISEASE_Uveal_melanoma @DISEASE_MESH:C536494 @@@UM@@@ therapy as well as for repairing @<m>DISEASE_Vitreous_Hemorrhage</m> @DISEASE_MESH:D014823 @@@vitreous deficiency@@@ and preserving visual function. ", "citations": {"NLM": "Yang M, Li J, Liu Z, Zhang H, Liu J, Liu Y, Zhuang A, Zhou H, Gu P, Fan X. An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy. Biomater Sci. 2022 Dec 6;10(24):7077-7092. PMID: 36326609", "BibTeX": "@article{36326609, title={An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy.}, author={Yang M and Li J and Liu Z and Zhang H and Liu J and Liu Y and Zhuang A and Zhou H and Gu P and Fan X}, journal={Biomater Sci}, volume={10}, number={24}, pages={7077-7092}}"}}]}